期刊文献+

ALOX5AP基因多态性与动脉粥样硬化性脑梗死相关性 被引量:5

ASSOCIATION OF ALOX5AP POLYMORPHISMS WITH ATHEROSCLEROTIC CEREBRAL INFARCTION
暂未订购
导出
摘要 目的探讨5-脂氧合酶激活蛋白(ALOX5AP)基因多态性与动脉粥样硬化性脑梗死(ACI)的相关性。方法应用聚合酶链反应一限制性片段长度多态性(PCR—RFLP)分析法,检测412例ACI病人和472例性别、年龄与ACI病人相匹配的健康人群ALOX5AP基因(SGl3S114、SGl3S89、SGl3S32)多态性。结果病例组和对照组相比,SGl3S114位点等位基因T和基因型TT/TA分布差异具有统计学意义(x^2=21.63、10.99,P〈O.01)。应用多因素Logistic回归方法排除传统危险因素的影响后,携带SGl3S114TT/TA基因型和SG13S32CC/CA基因型的人群ACI发病风险分别是携带AA基因型人群的2.35倍(OR=2.35,95%CI=1.46~3.78,P〈0.01)和1.43倍(OR=1.43,95%CI=1.02~2.01,P〈O.05)。经传统危险因素糖尿病分层后,SGl3S32CC/CA基因型能够明显增加糖尿病人群患ACI的风险(OR=3.27,95%CI=1.55~6.88,P〈o.01)。单倍型TGC作为一种危险单倍型(OR=1.46,95%CI=1.17~1.82,P〈0.01)可以增加ACI的发病风险。结论ALOX5AP基因多态性与ACI的发生密切相关,且该基因可明显增加糖尿病人群ACI的发病风险。 Objective To investigate the association of 5-1ipoxygenase activating protein (ALOX5AP) gene polymor- phisms with atherosclerotic cerebral infarction (ACI). Methods By using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis, three polymorphisms of the activating 5-1ipoxygenase (ALOXSAP) gene (SG13Sl14, SG13S89,SG13S32) were analyzed in 412 patients with ACI and 472 age- and sex-matched healthy controls. Results Significant differences at allele T and genotype TT/TA distributions of SG13S114 were observed between the ACI and the control (x^2 : 21.63, 10.99 ;P〈0.01). Multivariate logistic regression analysis revealed that SG13Sl14 genotype TT/TA and SG13S32 genotype CC/CA had a 2.35-fold (OR :2.35,95 %CI= 1.46--3.78,P〈0.01) and a 1.43-fold (OR : 1.43,95%CI: 1.02--2.01,P〈0.05) increased risk for ACI patients compared with AA genotype, respectively. Stratification based on the status of history of diabetes revealed that SG13S32 genotype CC/CA increased the risk of ACI in patients with diabetes (OR : 3.27,95 % CI : 1.55 -- 6.88, P (0.01). The haplotype analysis showed that the haplotype TGC (OR = 1.46,95 % CI = 1.17 - 1.82, P 〈 0.01) was associated with an in- creased risk for ACI. Conclusion Genetic polymorphism of ALOXSAP was closely associated with ACI and it can obviously in- crease the risk of ACI in patients with diabetes.
出处 《青岛大学医学院学报》 CAS 2013年第6期471-475,共5页 Acta Academiae Medicinae Qingdao Universitatis
基金 山东省自然科学基金资助项目(ZR2010HM061)
关键词 花生四烯酸盐5-脂氧合酶 动脉粥样硬化 脑梗死 多态性 单核苷酸 白三烯类 arachidonate 5-1ipoxygenase Ltheroselerosis brain infarction polymorphism, single nueleotide leukotri-
  • 相关文献

参考文献17

  • 1YUAN M, WANG X, ZHAN Q, et al. Association of PTEN genetic polymorphisms with atherosclerotic cerebral infarction in the Han Chinese population[J]. J Clin Neurosci, 2012, 19 (12) : 1641-1645.
  • 2战晶晶,金丽英,王海萍,张晨,宋岩.缺血性脑血管病病人SAA水平检测与意义[J].青岛大学医学院学报,2011,47(2):110-112. 被引量:5
  • 3LIBBY P. Inflammation in atherosclerosis[J]. Nature, 2002, 420(6917) :868-874.
  • 4任敦林,刘丽君,宋岩,战晶晶,王海萍,张晨.IL-18基因启动子多态性与缺血性脑卒中关系[J].齐鲁医学杂志,2012,27(3):223-225. 被引量:7
  • 5TABIBIAZAR R, WAGNER R A, ASHLEY E A, et al. Sig- nature patterns of gene expression in mouse atherosclerosis and their correlation to human coronary disease[J]. Physiol Genomics, 2005,22(2) :213-226.
  • 6ADAMS H P JR, BENDIXEN B H, KAPPELLE L J, et ai. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment[J]. Stroke, 1993,24(1) : 35- 41.
  • 7HELGADOTTIR A, MANOLESCU A, THORLEIFSSON G, et al. The gene encoding 5-1ipoxygenase activating protein confers risk of myocardial infarction and stroke[J]. Nat Genet, 2004,36(3) :233-239.
  • 8DUPONT W D, PLUMMER W D Jr. Power and sample size calculations for studies involving linear regression[J]. Control Clin Trials, 1998,19(6) :589-601.
  • 9YANDAVA C N, KENNEDY B P, PILLARI A, et al. Cyto- genetic and radiation hybrid mapping of human arachidonate 5- lipoxygenase-activating protein (ALOXSAP) to chromosome 13q12[J]. Genomics, 1999,56(1) : 131-133.
  • 10EVANS J F, FERGUSON A D, MOSLEY R T, et al. What's all the FLAP about: 5-1ipoxygenase-activating protein inhibitors for inflammatory diseases [J]. Trends Pharmacol Sei, 2008,29(2) :72-78.

二级参考文献40

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33093
  • 2洪柳,莫亚杰.颈动脉粥样硬化斑块稳定性与脑梗死的相关研究[J].中西医结合心脑血管病杂志,2007,5(3):201-202. 被引量:11
  • 3RUBATTU S, GILLBERTI R, VOLPE M. Etiology and pathophysiology of stroke as a complex trait[J]. Am J Hyper tens, 2000,13(10):1139-1148.
  • 4FLEX A, GAETANI E, PAPALEO P, et al. Proinflammatory genetic profiles in subjects with history of ischemic stroke [J]. Stroke, 2004,35(10):2270-2275.
  • 5VERMA S, SZMITKO P E, RIDKER P M. C-reactive protein comes of age[J]. Nat Clin Pract Cardiovase Med , 2005, 2 (1) :29-36.
  • 6O'BRIEN K D, CHAIT A. Serum amylold A: the other inflam matory protein[J]. Curr Atheroscler Rep, 2006,8(1) :62-68.
  • 7WANG Z H, HAN Z Y. TOAST classification of acute ischemic stroke[J]. Clin Neurol, 2007,20(5) :392.
  • 8ALAN C, CHANG Y H, JOHN F O, et al. Lipoprotein-asso- elated inflammatory proteins: markers or mediators of cardio- vascular d sease[J]? J Lipid Res, 2005,46:389-397.
  • 9RIDKER P M, HENNEKENS C H. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease inwomen[J]. N Engl J Med, 2000,342(12):836-884.
  • 10I.OFTUS I M, NAYLOR A R, GOODALL S. Increased ma trix metalloproteinases-activity in unstable carotid plaque. A potential role on acute plaque disruption[J]. Stroke, 2003,31 (1) :40-47.

共引文献15

同被引文献83

引证文献5

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部